Wearable Digital Health Technologies

Credit

Handouts/Brochure

Speaker

Paul Langlois, APN, PhD, CCRN, CCNS Related seminars and products

---

Paul Langlois, APN, PhD, CCRN, CCNS, is a critical care clinical specialist in the surgical, medical, neurologic, burn, CCU, and trauma ICUs of Cook County Hospital, Chicago. Drawing on over 40 years of experience assessing and managing patients with life-threatening diseases, Dr. Langlois provides advanced-level training to nurses, physician assistants, nurse practitioners, respiratory therapists, and physicians.

Dr. Langlois is committed to providing the highest quality of care to patients through advanced education. His presentations are evidence-based, timely, and provide participants with numerous case studies to facilitate critical thinking. As a bedside clinical nurse specialist, he has developed several institution-wide protocols for the multidisciplinary assessment and management of infectious disease and multi-system organ failure patients.

His presentations are enthusiastically delivered and offer highly practical tips that help make the most challenging concepts easy to understand. Linking knowledge to clinical practice is the goal of every educational program.  

 

Speaker Disclosures:
Financial: Dr. Paul Langlois has employment relationship with Cook County Hospital and Emergency Care Consultants. He receives a speaking honorarium and recording royalties from PESI, Inc. He has no relevant financial relationships with ineligible organizations.
Non-financial: Dr. Paul Langlois is a member of the American Nurses Association, the American Association of Critical Care Nurses, and the Society of Critical Care Medicine.

Additional Info

Access never expires for this product.

Visit our FAQ page at www.pesi.com/faq or contact us at www.pesi.com/info

Objectives

1. Evaluate wearable digital health technologies (DHT) devices which have allowed clinicians to monitor patients remotely. 

2. Analyze how wearable DHT can be used in each of the following: cardiovascular conditions, monitoring for seizure disorders and detecting psychological depressive states. 

3. Discriminate data ownership concerns as applies to the patient, healthcare system, app providers and device manufacturers. 

4. Appraise the future of wearable DHT as related to bridging the digital divide and improved quality of healthcare delivery. 

Outline

Patient Data Monitoring with Wearable Digital Health Technologies (DHT) 

• DHT as a complement to clinical judgement 

• Pulse rate 

• ECG chest patch for continuous ECG strip recording 

• Blood sugar monitoring without finger stick 

• Smart tattoos to monitor hydration and blood pressure 

• Smart socks to monitor blood flow and inflammation 

• Smart rings for monitoring body temperature, heart rate, sleep patterns 

• Smart necklace to report falls 

• Smart otoscope to detect otitis and foreign bodies 

• Smart glasses to minimize blind spots in macular degeneration 

• Devices to detect seizure disorder 

• Devices to detect psychological depressive disorder 

Data Ownership Issues and Concerns 

• Patient 

• Healthcare system 

• App providers 

• Device manufacturer 

• Data aggregators 

DHT Use in Research 

• Hawthorne effect 

• Placebo and nocebo effects 

DHT and Artificial Intelligence 

Cybersecurity and Infrastructure Guidelines 

• FDA mandates 

• Signal quality 

• Data breaches 

Reimbursement for the DHT Equipment 

Target Audience

• Physicians
• Physician Assistants